TrialApplied health economics and health policy2019

Phase I/II Clinical Trial-Based Early Economic Evaluation of Acalabrutinib for Relapsed Chronic Lymphocytic Leukaemia.

Rick A Vreman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.